Stockholm Life gathers
life science in Stockholm

This is a guest blog for all of you in the life science community in the Stockholm area. Do you want to write a blog post or do you know someone who should? Please contact Stockholm Science City at

You are here

Ben Libberton

Making the invisible visible at MAX IV

Sweden has quietly become a superpower in accelerator technology, get ready for its impact in biology, says Ben Libberton, Science Communicator at MAX IV. 

Björn Arvidsson, Head of Policy and Communications, Roche

Digitalization opens up for new actors within life science

We would like to believe that we can foresee what will be successful. At the same time, history shows that even at our best we can only predict progress occurring incrementally – with minor changes in existing activities. When technologies that handle our challenges in a completely different way appear, we often reject them – since our cognitive ability is based on what we already believe in, and therefore prevent us from understanding its full value.

Creative, innovative Berlin

During three intense days in the end of January and beginning of February, some 40 delegates visited Berlin for the biannual international study mission by The Council for the Stockholm Mälar Region (Mälardalsrådet). The aim of the delegation was to "approach different angles of sustainable competitiveness with a special focus on how collaboration leads to strong competitive regions". Ylva Williams, CEO of Stockholm Science City was one of the delegates.

Explore the opportunities of life science in the U.S

Ever wondered if the grass is greener on the other side of the Atlantic Ocean? If yes, you have good reasons to. America is by far the biggest actor in the life science industry with the most successful and thriving clusters in the world.

Paula Hassoon, CEO, Global Pharma Consulting

Arab Health as a business platform for Swedish life science innovators

During the annual Arab Health exhibition, private Swedish B2B consultant Global Pharma Consulting hosted The Innovation Pavilion by Sweden. Paula Hassoon, CEO at Global Pharma, gives us an update from the exhibition as well as her thoughts of the arabic healthcare market and the opportunities for Swedish health companies to do business. 

Per Lek, PhD

The transformation of clinical trials – the Direct to Patient Model

On February the 15th, Stockholm Science City and World Courier is hosting a seminar focusing on clinical trials in a home environment. The topic is more relevant than ever in a changing pharmaceutical industry. One ongoing transformation is the shift towards becoming health companies, i.e. increasing the offering from “only” a drug provider to a wider offering. 

Håkan Lavebratt, PhD Engineering. Key Account Manager Medtech, AMB

With insight into the development of medtech products

Medtech is a broad area that includes an unlimited number of different products used in healthcare. An important component in many medical devices is the plastic parts required for the final product and in order to reach the market, a variety of skills are needed. At a seminar on January 23, we will learn more about medtech plastic details from four companies. We took the chance to ask questions to the seminar’s moderator Håkan Lavebratt from ABM Industri, one of the participants you have the opportunity to meet during the upcoming seminar.

Björn Sjöstrand, CEO Scandinavian Biopharma

Drinkable vaccine against ETEC in development: a life saver for children in developing countries

Scandinavian Biopharma is a Swedish research-based biotech company located in Solna. They are now developing a vaccine to prevent ETEC, a diarrheal disease that anually affects 400 million people. CEO at Scandinavian Biopharma, Björn Sjöstrand, answers our questions about the project and the vaccine that hopefully will protect travelers from diarrhea and especially save children in developing countries from malnutrition.

Johan Gomez de la Torre, Business Development Manager, Stockholm Science City Foundation

EMA is moving to Amsterdam

The expectations all around Europe were high on November 20 when representatives from the EU member states met to decide where the European Medicinal Agency should relocate. After a spectacular voting exercise, Amsterdam came out on top. The process to decide where to move the agency started officially in the early summer 2017 and intensified during the fall. Stockholm fell short in the end but the Swedish candidature made the regional collaboration to gain momentum during the year which hopefully will have positive effects on the life science sector in the region.


Anna Starbrink. Foto: Frida Rönnholm, People76.

World-class healthcare, research and education when the new Karolinska University Hospital opens

The full opening of Karolinska University Hospital's new building is coming up. It will enable a highly modern care with the patient at center. Anna Starbrink, County Council Healthcare Commissioner, Stockholm County Council, gives us her thoughts on the NKS project and what opportunities the new hospital will bring to the patients and to the region.